Nrf2 Signaling and the Slowed Aging Phenotype: Evidence from Long-Lived Models

Oxid Med Cell Longev. 2015:2015:732596. doi: 10.1155/2015/732596. Epub 2015 Oct 25.

Abstract

Studying long-lived animals provides novel insight into shared characteristics of aging and represents a unique model to elucidate approaches to prevent chronic disease. Oxidant stress underlies many chronic diseases and resistance to stress is a potential mechanism governing slowed aging. The transcription factor nuclear factor (erythroid-derived 2)-like 2 is the "master regulator" of cellular antioxidant defenses. Nrf2 is upregulated by some longevity promoting interventions and may play a role in regulating species longevity. However, Nrf2 expression and activity in long-lived models have not been well described. Here, we review evidence for altered Nrf2 signaling in a variety of slowed aging models that accomplish lifespan extension via pharmacological, nutritional, evolutionary, genetic, and presumably epigenetic means.

Publication types

  • Review

MeSH terms

  • Aging*
  • Animals
  • Caloric Restriction
  • Longevity*
  • Models, Biological*
  • Myocardium / metabolism
  • NAD(P)H Dehydrogenase (Quinone) / metabolism
  • NF-E2-Related Factor 2 / metabolism*
  • Signal Transduction
  • Superoxide Dismutase / metabolism

Substances

  • NF-E2-Related Factor 2
  • Superoxide Dismutase
  • NAD(P)H Dehydrogenase (Quinone)